Skip to main content

Correction to: an economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France and Spain

The Original Article was published on 21 June 2023

BMC Pulmonary Medicine (2023) 23:220

https://doi.org/10.1186/s12890-023-02516-2

Following publication of the original article, it was brought to the authors’ attention that the names of collaborators had been omitted from the acknowledgements and that the funding details were incorrect.

The details of the collaborators added to the acknowledgements are as follows:

We thank the following collaborators for their contributions: Fernando Fernandez (Head of Microbiology Unit), Francisco Rivas (Coordinator of Methodology Unit) and Marilina Garcia (RAPID-COVID Postdoctoral Researcher) all from Hospital Costa del Sol, Marbella, Spain, and Martin Rottman from Faculté de Médecine Simone Veil, Université de Versailles St Quentin, France and Innovative Biomarkers Platform, Hôpital Raymond Poincaré, France.

The details of the funding have been changed and the updated text now reads:

This project received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101005144 awarded to Genefirst and collaborating organisations. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

These errors have since been corrected in the original article. The authors apologize for any inconvenience caused.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susie Huntington.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s12890-023-02516-2.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miners, L., Huntington, S., Lee, N. et al. Correction to: an economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France and Spain. BMC Pulm Med 23, 296 (2023). https://doi.org/10.1186/s12890-023-02572-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12890-023-02572-8